10-Q: Hims & Hers Health Reports Strong Q1 2024 Results, Revenue Jumps 46%

Sentiment:

Quarterly Report


Hims & Hers Health, Inc. announced a 46% increase in revenue for the first quarter of 2024, driven by growth in online sales and subscribers.

Better than expectedThe company's net income of $11.1 million is a significant improvement compared to a net loss of $10.1 million in the same quarter last year.The company's adjusted EBITDA of $32.3 million is a substantial increase compared to $6.1 million in the same quarter last year.The company's free cash flow of $11.9 million is a significant increase compared to $7.0 million in the same quarter last year.

Summary

  • Hims & Hers Health, Inc. reported a 46% increase in total revenue for the first quarter of 2024, reaching $278.2 million, compared to $190.8 million in the same period last year.
  • Online revenue grew by 45% to $267.8 million, while wholesale revenue increased by 58% to $10.4 million.
  • The company's subscriber base grew by 41% year-over-year, reaching 1.7 million subscribers.
  • Average order value (AOV) increased by 21% to $109, driven by newer product offerings and a shift towards longer-duration subscriptions.
  • The company achieved net income of $11.1 million, a significant improvement compared to a net loss of $10.1 million in the first quarter of 2023.
  • Adjusted EBITDA for the quarter was $32.3 million, compared to $6.1 million in the same period last year.
  • Free cash flow was $11.9 million for the quarter, compared to $7.0 million in the same period last year.

Sentiment

Score: 8

Explanation: The document shows strong financial performance with significant revenue growth, improved profitability, and positive cash flow. The company is executing well on its strategy, but there are still risks related to competition, regulation, and the need for continued investment.

Positives

  • The company experienced significant revenue growth across both online and wholesale channels.
  • The increase in subscribers indicates strong customer acquisition and retention.
  • The rise in AOV suggests customers are purchasing more per order, likely due to new offerings and longer subscriptions.
  • The company achieved profitability with a net income of $11.1 million, a major turnaround from the previous year's loss.
  • Adjusted EBITDA and free cash flow both showed substantial improvements, indicating better operational efficiency and cash management.

Negatives

  • Marketing expenses increased by 34% to $130.6 million, reflecting the company's investment in customer acquisition.
  • Operations and support expenses increased by 48% to $38.7 million, driven by increased employee compensation and fulfillment costs.
  • Technology and development expenses increased by 43% to $15.3 million, due to increased employee compensation and technology costs.
  • The company continues to maintain a full valuation allowance on deferred tax assets.

Risks

  • The company's future performance depends on its ability to attract new customers and retain existing ones.
  • Changes in laws and regulations could impact the company's marketing activities and customer acquisition costs.
  • The company faces intense competition from other telehealth providers, traditional healthcare providers, and technology companies.
  • The company's brand reputation could be harmed by negative publicity or issues with the quality of services provided by its network of providers.
  • The company's pharmacy business is subject to additional healthcare laws and regulations, increasing compliance obligations.
  • Security breaches or loss of data could compromise sensitive information and expose the company to liability.
  • The company may require additional capital to support its growth, which may not be available on acceptable terms.
  • The dual-class stock structure concentrates voting power with the CEO, limiting investor influence.
  • The market price of the company's Class A common stock may be volatile.

Future Outlook

The company expects to continue to invest in its fulfillment and operating capabilities, marketing, product offerings, and customer experience to drive long-term growth. They also plan to expand into new health and wellness specialties.

Management Comments

  • Management believes that they have the technical platform, distributed provider network, and access to clinical capabilities to lead the migration of routine office visits to a digital format.
  • Management intends to continue to invest in fulfillment and operating capabilities, including Affiliated Pharmacies and warehousing facilities.
  • Management expects to continue to make significant investments in marketing to acquire new customers.
  • Management is working to enhance offerings and expand the breadth of health and wellness products and services offered on their websites and mobile applications.

Industry Context

The results reflect the continued growth and adoption of telehealth services, with Hims & Hers leveraging its digital platform to expand its reach and offerings in various health and wellness categories. The company's focus on direct-to-consumer models and subscription-based services aligns with broader trends in the healthcare industry.

Comparison to Industry Standards

  • Hims & Hers' 46% revenue growth significantly outpaces the average growth rate of many traditional healthcare providers, which often see single-digit growth.
  • The company's focus on direct-to-consumer telehealth is comparable to companies like Teladoc Health, but Hims & Hers differentiates itself with a strong emphasis on lifestyle and wellness products.
  • The 41% growth in subscribers is a strong indicator of market acceptance and customer loyalty, which is a key metric for subscription-based businesses.
  • The increase in AOV to $109 demonstrates the company's ability to upsell and cross-sell products and services, a strategy also employed by successful e-commerce companies like Amazon.
  • The achievement of net income and positive free cash flow is a significant milestone, as many telehealth companies are still struggling with profitability, such as those in the digital health space like GoodRx and Amwell.

Related Party Transactions

  • The company recorded $1.2 million within operating expenses for payments made to Vouched, a related-party company that provides identity verification services.

Stakeholder Impact

  • Shareholders will benefit from the company's improved financial performance and growth prospects.
  • Employees may benefit from the company's growth and expansion.
  • Customers will benefit from the company's expanded offerings and improved customer experience.
  • Suppliers and partners will benefit from the company's increased business activity.

Next Steps

  • The company intends to continue to invest in its fulfillment and operating capabilities.
  • The company plans to continue to make significant investments in marketing to acquire new customers.
  • The company will continue to invest in product offerings and customer experience.
  • The company will continue to expand into new health and wellness specialties.

Key Dates

DateDescription
2020-06-17Grant date of stock options to the CEO with vesting conditions based on share price or acquisition.
2021-01-01Adoption of the 2020 Equity Incentive Plan and the Employee Stock Purchase Plan (ESPP).
2021-02-01The $22.99 per share price threshold related to awards for the 3,246,139 stock options was achieved.
2021-06-01Grant date of restricted shares of Class A common stock subject to vesting in connection with the acquisition of HHL.
2021-07-01Grant date of restricted shares of Class A common stock subject to vesting in connection with the acquisition of Apostrophe.
2022-02-24Grant date of stock options to the CEO with vesting conditions based on share price.
2023-03-01Grant date of performance RSUs to certain executive officers.
2023-10-26Board of Directors authorized a share repurchase program.
2024-02-28Grant date of performance RSUs to certain executive officers and senior leadership.
2024-03-31End of the first quarter of 2024.
2024-05-03Date of share information.

Keywords

telehealth, online pharmacy, subscription services, digital health, healthcare, e-commerce, direct-to-consumer, sexual health, dermatology, mental health, weight loss

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.